Ovarian toxicity after chemotherapy: possible association with ifosfamide administration.
Palmert
Mark R
MR
Division of Endocrinology, Department of Medicine, Children's Hospital, Boston, MA, USA. mrp13@po.cwru.edu
Alexander
Sarah W
SW
Goorin
Allen M
AM
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D019584:Hot Flashes / Q000139:chemically induced; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000009:adverse effects*; D008599:Menstruation Disturbances / Q000139:chemically induced; D012516:Osteosarcoma / Q000150:complications / Q000188:drug therapy; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced* / Q000175:diagnosis
D000970:Antineoplastic Agents; D007069:Ifosfamide